Voltaren SR 100mg film-coated tablets
Indication
In post-traumatic and post-operative inflammatory conditions, Voltaren rapidly relieves:1
Spontaneous pain
Inflammatory swelling
Pain on movement
Wound edema
Voltaren® Sustained release is indicated for the treatment of:
Post-traumatic and post-operative pain, inflammation, and swelling as in orthopedic surgery1
Dosage
Image
| The recommended initial daily dose is 100 to 150 mg, administered as 1 tablet of Voltaren sustained-released 100 mg or as 2 tablets of Voltaren sustained-released 75 mg.1 |
Image
| In milder cases, as well as for long-term therapy, 75 to 100 mg daily is usually sufficient.1 |
Image
| Where the symptoms are most pronounced during the night or in the morning, Voltaren sustained-release 75 mg and 100 mg should preferably be taken in the evening.1 |
For Voltaren® SR. Abbreviated prescribing information
For Voltaren® SR. Abbreviated prescribing information
References
Voltaren® SR film coated tablets. Egyptian Drug Authority (EDA) approved leaflet, approval date: 27/1/2025.
Approved by Egyptian Drug Authority: HF0082OA4731/092025. Invalidation date: 01/09/2027.
Kindly report any violated online promotional, educational and awareness material not having this message to The General administration for Regulation of Marketing & Advertising Materials at: www.edaegypt.gov.eg
Image
|
HF0082OA4731/092025 |
Adverse Events Reporting We encourage using the following Electronic reporting tool for reporting into the safety database directly: |